Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.6915
-0.0335 (-4.62%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $30.08 million. The enterprise value is $29.93 million.

Market Cap30.08M
Enterprise Value 29.93M

Important Dates

The last earnings date was Thursday, August 13, 2026, after market close.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

ESLA has 43.50 million shares outstanding. The number of shares has increased by 10.44% in one year.

Current Share Class 43.50M
Shares Outstanding 43.50M
Shares Change (YoY) +10.44%
Shares Change (QoQ) +2.08%
Owned by Insiders (%) 2.31%
Owned by Institutions (%) 1.89%
Float 14.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio 0.20
Quick Ratio 0.02
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -251.86%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 130.29%
Weighted Average Cost of Capital (WACC) 9.14%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -25
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.14% in the last 52 weeks. The beta is 0.89, so ESLA's price volatility has been lower than the market average.

Beta (5Y) 0.89
52-Week Price Change -34.14%
50-Day Moving Average 0.81
200-Day Moving Average 1.22
Relative Strength Index (RSI) 37.57
Average Volume (20 Days) 29,217

Short Selling Information

The latest short interest is 61,410, so 0.14% of the outstanding shares have been sold short.

Short Interest 61,410
Short Previous Month 48,054
Short % of Shares Out 0.14%
Short % of Float 0.43%
Short Ratio (days to cover) 1.69

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -9.68M
Pretax Income -10.01M
Net Income -10.01M
EBITDA n/a
EBIT -9.68M
Earnings Per Share (EPS) -$0.25
Full Income Statement

Balance Sheet

The company has $146,670 in cash and no debt, with a net cash position of $146,670 or $0.00 per share.

Cash & Cash Equivalents 146,670
Total Debt n/a
Net Cash 146,670
Net Cash Per Share $0.00
Equity (Book Value) -7.43M
Book Value Per Share -0.17
Working Capital -7.43M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.38M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing n/a
Free Cash Flow -9.38M
FCF Per Share -$0.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.44%
Shareholder Yield -10.44%
Earnings Yield -33.29%
FCF Yield -31.20%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2